Maternal activating mutation of the calcium-sensing receptor: Implications for calcium metabolism in the neonate

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 4, 2004, Pages 673-677

  Pagan, Yanira L ^a   Hirschhorn, Joel ^a   Yang, Bing ^b   D'Souza Li, Lilia ^b   Majzoub, Joseph A ^a   Hendy, Geoffrey N ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Autosomal dominant hypocalcemia; Calcium sensing receptor; Neonatal calcium metabolism

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CALCIUM DERIVATIVE; CALCIUM SENSING RECEPTOR; GENOMIC DNA; PARATHYROID HORMONE; VITAMIN;

ALLELE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CASE REPORT; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; EXTRACHROMOSOMAL INHERITANCE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE; HORMONE RESPONSE; HUMAN; HYPOCALCEMIA; INFANT; KIDNEY CALCIFICATION; KIDNEY FAILURE; MATERNAL DISEASE; NEWBORN; NEWBORN CARE; PARATHYROID GLAND;

EID: 3142683281     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2004.17.4.673     Document Type: Article

References (20)

1. 2+-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580.
2. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001; 81: 239-297.
3. Janicic N, Soliman E, Pausova Z, Seldin MF, Riviere M, Szpirer J, Hendy GN. Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mamm Genome 1995; 6: 798-801.
4. Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DEC. Mutations of the calcium-sensing receptor (CASR) in Familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2000; 16: 281-296.
5. 2+-sensing receptor gene mutation. Nat Genet 1994; 8: 303-307.
6. 2+-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 1996; 5: 601-606.
7. Pidasheva D, D'Souza-Li L, Cole DEC, Hendy GN. CASRdb, calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. J Bone Miner Res 2002; 17 (Suppl 1): S494 (Abst. M441).
8. Pearce SHS, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor gene. N Engl J Med 1996; 335: 1115-1122.
9. Lienhardt A, Bai M, Lagarde JP, Rigaud M, Zhang Z, Jiang Y, Kottler ML, Brown EM, Garabedian M. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 2001; 86: 5313-5323.
10. 2+ and maximal signal transduction. Pediatr Res 1997; 42: 443-447.
11. 2+-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet 1995; 56: 880-886.
12. D'Souza-Li L, Yang B, Canaff L, Bai M, Hanley DA, Bastepe M, Salisbury SR, Brown EM, Cole DEC, Hendy GN. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2002; 87: 1309-1318.
13. Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 2002; 277: 30337-30350.
14. Sato K, Hasegawa Y, Nakae J, Nanao K, Takahashi I, Tajima T, Shinohara N, Fujieda K. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene. J Clin Endocrinol Metab 2002; 87: 3068-3073.
15. Winer KK, Yanovski JA, Sarani B, Cutler GB Jr. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 1998; 83: 3480-3486.
16. 2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharm Exp Ther 2001; 299: 323-331.
17. Kovacs CS, Ho-Pao CL, Hunzelman JL, Lanske B, Fox J, Seidman JG, Seidman CE, Kronenberg HM. Regulation of murine fetal-placental calcium metabolism by the calcium-sensing receptor. J Clin Invest 1998; 101: 2812-2820.
18. Gherman RB, Bowen E, Eggleston MK, Teague KE, Sayles T, Brown E, Pollak MR. Successful pregnancy outcome in a woman with a gain-of-function mutation of the calcium-sensing receptor. J Reprod Med 1999; 44: 745-747.
19. Thomas AK, McVie R, Levine SN. Disorders of maternal calcium metabolism implicated by abnormal calcium metabolism in the neonate. Am J Perinatol 1999; 16: 515-520.
20. Kovacs CS. Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab 2001; 86: 2344-2348.